Science and technology intermediary services for SMEs: A guide via practices Supporting Potential & Existing Research Intensive SMEs 2008 Download Introduction This report introduces experiences and practices from seven European regions in the fields of Science and Technology (S&T) interme...

Catching up, forging ahead or falling behind? Central and Eastern European development in 1990-2005 Innovation: The European Journal of Social Science Research Marek Tiits, Rainer Kattel, Tarmo Kalvet, Dorel Tamm (2008) Download   Abstract This paper aims to assess the economic development and development policies in the Central and Ea...

Globalization leads to greater challenges for Research and Technology Development (RTD) policies and for the competitiveness of technology oriented SMEs. However, regional innovation policy-making is in need of innovation itself: It has to be more dynamic and adaptive. This can be reached by integrating RTD issues more coherently into str...

  Technology-Intensive FDI and Economic Development in A Small Country – The Case of Estonia Marek Tiits (2007) Download   Abstract. This article reviews the role of foreign direct investment in industrialisation of various catching-up economies and draws based on this lessons for policy-making in small countries. The author states th...

Policy Recommendations Innovation Financing in the European Medical Device Sector INJECTION (2007) Download   Introduction The Policy Recommendations document outlines the knowledge obtained by the InJection network on innovation financing for the medical device industry and provide recommendations for potential actions, which can be imple...

Comprehensive Regional Innovation Policy Impact Assessment scheme EURO-COOP (Regional Innovation Policy Impact Assessment and Benchmarking Process: Cooperation for Sustainable Regional Innovation), 2007 Download   OVERVIEW This deliverable sets out the final scope and method of the ‘Regional Innovation Policy Impact Assessment’ method ...

Synthesis report on Biotech National and EU Policies AFIBIO Network (Access to Finance in The Biotechnology Sector), 2007 Download   The approach This review was prepared by the Institute of Baltic Studies (IBS) in the framework of the AFIBIO project based on various national policy documents on biotech funding identified by the members o...

Kaupmeeste riik Marek Tiits (toimetaja) Eesti Teaduste Akadeemia, 2007. ISBN: 978-9949-15-165-3 Raamatu elektrooniline versioon: Kaupmeeste riik (1,7 MB) Osta raamat Apollo poodidest! Sissejuhatus Soodne geograafiline asend Põhjamaade läheduses, 1990ndate aastate alguse radikaalsed majandusreformid, mad...

The RegStrat-project, which ran from 2007 until March 2009, was based on an ambitious integrating approach harnessing synergies from various knowledge stocks regarding strategic policy intelligence (SPI) tools, at different governance levels, in different policy and policy research fields, and in different actor communities of Europe's regional, na...

Research and Technological Development is essential for the functioning and sustainability of the European economy and therefore in the center of EU’s development agenda. Special attention has been paid to the Small and Medium Enterprises. Micro, small and medium-sized enterprises are socially and economically important, since they represent 99 %...

Intra-Industry trade in the Baltic Sea region Working Paper 2/2006 Marek Tiits, Juhan Jüriado (2006) Download   Executive summary The purpose of this paper is to analyse economic integration in the Baltic Sea Region as it has emerged from mid-1990s. More importantly, we seek to assess the quality of integration as conferred by the d...

Overview of the Biotech–Health Sector in Europe Project: AFIBIO (Access to Finance in the Biotech Sector) Workpackage 1 – Identification and analysis of the biotech sector specificities relevant to access to finance (2006) Download   Introduction The Workpackage 1 aims at a better and common understanding of biotech-health sector s...

Globalization of R&D and Developing Countries Proceedings of the Expert Meeting, Geneva, 24-26 January 2005 Download

Industrial and trade dynamics in the Baltic Sea region – the last two waves of European Union enlargement from a historic perspective Working Paper 1/2006 Marek Tiits (2006) Download   Executive summary The aim of this paper is to review the dynamics of economic development in the Baltic Sea region surrounding the last two waves of Europ...

Made in Estonia Marek Tiits, Rainer Kattel and Tarmo Kalvet ISBN: 9949108942 (trükis), 9985965817 (PDF) Raamatu elektrooniline versioon: Made in Estonia (1,6 MB) Osta raamat Apollo poodidest! The book is also available in English version. Sissejuhatus 1990ndad aastad on olnud Euroopa Liidu ja NATO...

The SUPER-SME project aims to contribute to the objective of raising the intensity of research expenditure and activity of enterprises in the participating regions through a mix of activities. This will be done in two main phases using a range of tools:   Phase 1: mapping S&T intermediation services and identifying gaps ...

This project was approved in the FP6-2004-KNOW-REG-2 call for proposals of the 6th Framework Programme. The specific programme covered was "Integrating and Strengthening the European Research Area" and the activity areas included were "Coherent development of research and innovation policies". The project will perform the comparative analysis ...

The project SupPolicy aims at supporting the sub-national and national research and innovation policy actors by providing a methodology to translate the results produced by innovation assessing tools into concrete policy making decisions. The aim is also to improve the effectiveness of the policy-cycle in order to increase the impact of public inte...

'Networking INnovation actors in the medical device sector' 8.6% of GDP in Europe is spent on health, of which 6.4% is for medical technology. Although this expenditure delivers an exceptional return on investment, there is a need for continual innovation. Increasing patient treatment and operating costs mean that the commercial prospe...

Commercialisation of first-class research and the development of the European Biotech Healthcare sector are problematic especially in terms of unmet financial needs and poor cooperation between sector actors. The lack of early-stage risk capital severely hampers the formation of innovative start-up companies: Europe's start-ups need new forms...